CompanyGraph
At a glance
- Depends onMidstream position: 6 outgoing, 8 incoming connections
- PositionGross margin is 22%, lower than 95% of its Medical Devices peers (median 61.5%)
- FinancialsLow earnings quality
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
0.32%Below 5Y avg (1.50%)
Annual Rate
CNY 0.05Paid annual
Payout Ratio
0.0%Sustainable
Last Ex-Dividend
Nov 26, 2025
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
4.16BCNY621.06M · vs all stocks (USD)
Revenue (TTM)
1.05BCNY156.11M · vs all stocks (USD)
Profit Margin
-6.32%vs Medical Devices peers
Beta
0.5250xvs all stocks
52-Week Change
84.29%vs all stocks
Market Capitalization
4.16BCNY621.06M · vs all stocks (USD)
Enterprise Value
4.04BCNY602.64M · vs all stocks (USD)
Forward P/E
23.12xvs Medical Devices peers
Price to Sales (TTM)
3.98xvs Medical Devices peers
Price to Book (MRQ)
3.73xvs Medical Devices peers
Enterprise to Revenue
3.86xvs Medical Devices peers
Gross Margin
22.02%vs Medical Devices peers
Profit Margin
-6.32%vs Medical Devices peers
Operating Margin
-13.29%vs Medical Devices peers
Return on Assets (TTM)
-1.41%vs Medical Devices peers
Return on Equity (TTM)
-4.76%vs Medical Devices peers
Revenue (TTM)
1.05BCNY156.11M · vs all stocks (USD)
Revenue per Share (TTM)
3.96CNYUpdated Sep 20, 2026Quarterly Revenue Growth
-0.30%vs Medical Devices peers
Gross Profit (TTM)
259.19MCNY38.68M · vs all stocks (USD)
EBITDA (TTM)
60.34MCNY9.00M · vs all stocks (USD)
Net Income (TTM)
-66.14MCNY-9.87M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
10.90%vs Medical Devices peers
Operating Cash Flow (TTM)
68.65MCNY10.24M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
79.47MCNY11.86M · vs all stocks (USD)
Trailing Annual Dividend Rate
0.0500CNYUpdated Sep 20, 2026Trailing Annual Dividend Yield
0.32%vs all stocks
5-Year Average Dividend Yield
1.50%vs all stocks
Payout Ratio
0.00%vs Medical Devices peers
Minority Interest (Equity)
74.65MCNYFY2025 · Dec 31, 2025Revenue
1.10BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
813.86MCNYFY2025 · Dec 31, 2025Gross Profit
281.53MCNYFY2025 · Dec 31, 2025Operating Income
-16.76MCNY-2.50M · vs all stocks (USD)
Pre-tax Income
-76.30MCNYFY2025 · Dec 31, 2025Income Tax Expense
-10.89MCNYFY2025 · Dec 31, 2025Net Income
-65.41MCNYFY2025 · Dec 31, 2025EBIT
-48.68MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
60.34MCNYFY2025 · Dec 31, 2025Research & Development
69.68MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
111.51MCNYFY2025 · Dec 31, 2025Other Operating Expenses
7.88MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
13.94MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
27.62MCNYFY2025 · Dec 31, 2025EPS (Basic)
-0.2624CNYFY2025 · Dec 31, 2025EPS (Diluted)
-0.2624CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
264.59MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
264.59MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
-65.41MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
-4.02MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
-287.44MCNYFY2025 · Dec 31, 2025Free Cash Flow
-442.25MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
661.80MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-65.41MCNYFY2025 · Dec 31, 2025Other Non-cash Items
42.87MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-186.80MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-78.11MCNYFY2025 · Dec 31, 2025Capital Expenditures
-154.81MCNYFY2025 · Dec 31, 2025Purchase of Investments
-89.00MCNYFY2025 · Dec 31, 2025Sale of Investments
340.31MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
96.51MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
371.50MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-304.08MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-30.65MCNYFY2025 · Dec 31, 2025Other Financing Charges
5.52MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
42.30MCNYFY2025 · Dec 31, 2025Shares Outstanding
264.61MSharesUpdated Sep 20, 2026Float Shares
184.32MSharesUpdated Sep 20, 2026% Held by Insiders
34.40%vs all stocks
% Held by Institutions
2.79%vs all stocks
Total Cash (MRQ)
606.75MCNY90.54M · vs all stocks (USD)
Total Cash per Share (MRQ)
2.32CNYUpdated Sep 20, 2026Total Debt (MRQ)
646.14MCNY96.42M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.5499xvs Medical Devices peers
Current Ratio (MRQ)
1.62xvs Medical Devices peers
Book Value per Share (MRQ)
4.22CNYUpdated Sep 20, 2026Total Assets
2.52BCNY376.38M · vs all stocks (USD)
Total Current Assets
1.28BCNYFY2025 · Dec 31, 2025Total Liabilities
1.31BCNYFY2025 · Dec 31, 2025Total Non-current Assets
1.25BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
507.58MCNYFY2025 · Dec 31, 2025Total Current Liabilities
802.54MCNYFY2025 · Dec 31, 2025Cash
665.61MCNYFY2025 · Dec 31, 2025Cash Equivalents
11.34MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
676.95MCNYFY2025 · Dec 31, 2025Accounts Receivable
242.14MCNYFY2025 · Dec 31, 2025Inventory
287.82MCNYFY2025 · Dec 31, 2025Accounts Payable
224.01MCNYFY2025 · Dec 31, 2025Short-term Debt
397.60MCNYFY2025 · Dec 31, 2025Other Current Liabilities
9.31MCNYFY2025 · Dec 31, 2025Long-term Debt
327.21MCNYFY2025 · Dec 31, 2025Other Non-current Liabilities
1.04MCNYFY2025 · Dec 31, 2025Common Stock (Book)
264.58MCNYFY2025 · Dec 31, 2025Retained Earnings
352.77MCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
1.21BCNY180.88M · vs all stocks (USD)
Treasury Stock
20.01MCNYFY2025 · Dec 31, 202552-Week Low
7.67CNYUpdated Sep 20, 202652-Week High
21.98CNYUpdated Sep 20, 202652-Week Change
84.29%vs all stocks
Beta
0.5250xvs all stocks
50-Day MA
16.42CNYUpdated Sep 20, 2026200-Day MA
14.85CNYUpdated Sep 20, 2026Avg 10-Day Volume
8.11MSharesUpdated Sep 20, 2026Avg 30-Day Volume
14.27MSharesUpdated Sep 20, 2026Diluted EPS (TTM)
-0.4000CNYUpdated Sep 20, 2026Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Gross margin is 22%, lower than 95% of its Medical Devices peers (median 61.5%)Significant
Gross margin: 0.22Industry median: 0.62Industry P5: 0.27Peers compared: 102
Financial Health
Low earnings qualitySignificant
Earnings Quality Score: -0.57
Altman Z-Score 2.7: safe zoneNotable
Altman Z-Score: 2.70
Supply Chain
Midstream position: 6 outgoing, 8 incoming connectionsNotable
Outgoing: 6.00Incoming: 8.00
High connectivity hub: 14 industry connectionsNotable
Total Connections: 14.00
Companies that share the same coordination system — how they create, deliver, or capture value.
Aura Biosciences Inc.
Tier 1ProductionApproval-Gated PipelineRule
TTY Biopharm Company Limited
Tier 1ProductionApproval-Gated PipelineRule
Lanzhou Foci Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Tianjin Lisheng Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Shanghai Sailun Biotech Co. Ltd.
Tier 1ProductionApproval-Gated PipelineRule
IOL Chemicals and Pharmaceuticals Ltd.
Tier 1ProductionApproval-Gated PipelineRule
CorMedix Inc.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Jianmin Pharmaceutical Group Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Nanjing Vishee Medical Technology Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Shattuck Labs Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk